MODEM

Check out this opinion piece 'Burning down the house: reinventing drug discovery in psychiatry for the development of targeted therapies' by Prof. Andrew H. Miller and Dr. Charles L Raison, writing about the importance of finding signs of mental illness in the body (biomarkers) to develop better treatments.

They believe that current ways of developing medications have not been very successful because we don't fully understand the physiological processes associated with psychiatric conditions. They suggest a new way of creating medicine by looking at how mental illness affects the body and finding specific systems and receptors we can target with medications.

A closer collaboration between academia, pharmaceutical companies, and the government to these aims will likely lead to better treatments for people who suffer from mental illness.

MODEM is a collaboration study with a pharmaceutical company aiming to do just that. If you are interested and would like to hear more, get in touch with us via [email protected].

You can read the article in full here:

Burning down the house: reinventing drug discovery in psychiatry for the development of targeted therapies - Molecular Psychiatry Despite advances in neuroscience, limited progress has been made in developing new and better medications for psychiatric disorders. Available treatments in psychiatry rely on a few classes of drugs that have a broad spectrum of activity across disorders with limited understanding of mechanism of ac...